Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"

Bradley S. Miller; Joanne C. Blair; Michael Højby Rasmussen; Aristides Maniatis; Rasmus Juul Kildemoes; Jun Mori; Michel Polak; Rikke Beck Bang; Volker Böttcher; Stefano Stagi; Reiko Horikawa

doi:10.1210/clinem/dgad095

Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"

Bradley S. Miller, Joanne C. Blair, Michael Højby Rasmussen, Aristides Maniatis, Rasmus Juul Kildemoes, Jun Mori, Michel Polak, Rikke Beck Bang, Volker Böttcher, Stefano Stagi, Reiko Horikawa

Pediatric Endocrinology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	e647-e648
Journal	The Journal of clinical endocrinology and metabolism
Volume	108
Issue number	8
DOIs	https://doi.org/10.1210/clinem/dgad095
State	Published - Jul 14 2023

PubMed: MeSH publication types

Clinical Trial, Phase III
Randomized Controlled Trial
Letter
Comment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1210/clinem/dgad095

Find It

Find It at U of M Libraries

Cite this

Miller, B. S., Blair, J. C., Rasmussen, M. H., Maniatis, A., Kildemoes, R. J., Mori, J., Polak, M., Bang, R. B., Böttcher, V., Stagi, S., & Horikawa, R. (2023). Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial". The Journal of clinical endocrinology and metabolism, 108(8), e647-e648. https://doi.org/10.1210/clinem/dgad095

Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial". / Miller, Bradley S.; Blair, Joanne C.; Rasmussen, Michael Højby et al.
In: The Journal of clinical endocrinology and metabolism, Vol. 108, No. 8, 14.07.2023, p. e647-e648.

Research output: Contribution to journal › Article › peer-review

Miller, BS, Blair, JC, Rasmussen, MH, Maniatis, A, Kildemoes, RJ, Mori, J, Polak, M, Bang, RB, Böttcher, V, Stagi, S & Horikawa, R 2023, 'Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"', The Journal of clinical endocrinology and metabolism, vol. 108, no. 8, pp. e647-e648. https://doi.org/10.1210/clinem/dgad095

@article{cde74f39084c427bb203580b571c3acf,

title = "Response to Letter to the Editor From Chatelain et al: {"}Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial{"}",

author = "Miller, {Bradley S.} and Blair, {Joanne C.} and Rasmussen, {Michael H{\o}jby} and Aristides Maniatis and Kildemoes, {Rasmus Juul} and Jun Mori and Michel Polak and Bang, {Rikke Beck} and Volker B{\"o}ttcher and Stefano Stagi and Reiko Horikawa",

year = "2023",

month = jul,

day = "14",

doi = "10.1210/clinem/dgad095",

language = "English (US)",

volume = "108",

pages = "e647--e648",

journal = "The Journal of clinical endocrinology and metabolism",

issn = "0021-972X",

publisher = "The Endocrine Society",

number = "8",

}

TY - JOUR

T1 - Response to Letter to the Editor From Chatelain et al

T2 - "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"

AU - Miller, Bradley S.

AU - Blair, Joanne C.

AU - Rasmussen, Michael Højby

AU - Maniatis, Aristides

AU - Kildemoes, Rasmus Juul

AU - Mori, Jun

AU - Polak, Michel

AU - Bang, Rikke Beck

AU - Böttcher, Volker

AU - Stagi, Stefano

AU - Horikawa, Reiko

PY - 2023/7/14

Y1 - 2023/7/14

UR - http://www.scopus.com/inward/record.url?scp=85164843493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85164843493&partnerID=8YFLogxK

U2 - 10.1210/clinem/dgad095

DO - 10.1210/clinem/dgad095

M3 - Article

C2 - 36869702

AN - SCOPUS:85164843493

SN - 0021-972X

VL - 108

SP - e647-e648

JO - The Journal of clinical endocrinology and metabolism

JF - The Journal of clinical endocrinology and metabolism

IS - 8

ER -

Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Cite this